Cover Image

Peak early‐phase enhancement ratio on contrast‐enhanced MRI to differentiate chromophobe renal cell carcinoma from oncocytoma

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Deanna Thorson, Davide Bova, Maria M. Picken, Marcus L. Quek, Gopal N. Gupta, Hiten D. Patel
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	BJUI Compass
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Utility of dynamic contrast enhancement for clinically significant prostate cancer detection
by: Eric V. Li, et al.
Published: (2024)

Utilization of cardiopulmonary bypass at radical nephrectomy for renal cell carcinoma with tumour thrombus
by: Chalairat Suk‐Ouichai, et al.
Published: (2024)

Effect of prior HoLEP procedure on multiparametric MRI accuracy in detection of prostate cancer
by: Austin Drysch, et al.
Published: (2025)

Contemporary assessment of diagnostic performance and histologic concordance of renal mass biopsy with surgical pathology
by: Mitchell M. Huang, et al.
Published: (2025)

Recurrence patterns following nephrectomy for renal cell carcinoma in a Danish nationwide cohort
by: Goran Bencina, et al.
Published: (2024)

Long‐term outcomes after cytoreductive partial nephrectomy for metastatic renal cell carcinoma
by: Andrea Lopez Sanmiguel, et al.
Published: (2026)

Neoadjuvant tislelizumab plus pazopanib in renal cell carcinoma with venous tumour thrombus: A retrospective study
by: Diliyaer Dilixiati, et al.
Published: (2025)

Machine learning analysis for detecting late recurrence and loss to follow‐up after renal cell carcinoma surgery
by: Kodai Sato, et al.
Published: (2024)

Efficacy of immune checkpoint inhibitor combination therapy prior to nephrectomy in advanced renal cell carcinoma: A retrospective pilot study
by: Sho Kiyota, et al.
Published: (2024)

Competing risk of death in patients with low, intermediate and high risk of recurrence after radical surgery for clear cell renal cell carcinoma
by: Anna Brännbäck, et al.
Published: (2025)

AI‐enhanced micro‐ultrasound improves detection of clinically significant prostate cancer at biopsy
by: Muhammad Imran, et al.
Published: (2026)

Cinematic rendering of 18 F‐DCFPyL PET/CT fusion data in a patient with metastatic clear cell renal cell carcinoma
by: Steven P. Rowe, et al.
Published: (2024)

PSMA PET/CT findings in high‐risk biochemical recurrence after local treatment of prostate cancer
by: Nicole Handa, et al.
Published: (2025)

A sustainable and expedited ‘One‐Stop’ prostate cancer diagnostic pathway to reduce environmental impact and enhance accessibility
by: Lorenzo Storino Ramacciotti, et al.
Published: (2024)

Improving clinical efficiency using retrieval‐augmented generation in urologic oncology: A guideline‐enhanced artificial intelligence approach
by: Harry Collin, et al.
Published: (2024)

Robotic radical prostatectomy in kidney transplant recipients: A propensity‐matched cohort study
by: Jennifer M. Slota, et al.
Published: (2025)

Predictive role of ABC transporters in the efficacy of enfortumab vedotin for urothelial carcinoma
by: Toshiki Kijima, et al.
Published: (2025)

Assessing EAU criteria for high‐risk upper tract urothelial carcinoma
by: Mahmoud Farzat, et al.
Published: (2025)

Emerging tools for the early detection of prostate cancer
by: Muhammad Haider, et al.
Published: (2025)

Hospital variation in the treatment of cT1a renal cancer
by: Cato Caroline Bresser, et al.
Published: (2026)

Urinary microbiota diversity and composition in patients with advanced renal cell cancer
by: Frederico Leal, et al.
Published: (2026)

Questionable role of opioids for analgesia in renal colic and its urological interventions
by: Anna Krieger, et al.
Published: (2025)

Reduced p63 expression is linked to unfavourable prognosis in muscle‐invasive urothelial carcinoma of the bladder
by: Kira Furlano, et al.
Published: (2024)

Robotic‐assisted approaches to urachal carcinoma: A comprehensive systematic review of the safety and efficacy outcomes
by: Caio Vinícius Suartz, et al.
Published: (2024)

Prognostic factors and treatment impact on overall survival in patients with renal neuroendocrine tumour
by: Olamide O. Omidele, et al.
Published: (2024)

Racial and socioeconomic disparities from time of diagnosis to treatment for small renal masses
by: Lila G. McGrath, et al.
Published: (2026)

A modified Delphi consensus statement on the role of biopsy in small renal masses
by: Darryl E. Bernstein, et al.
Published: (2025)

Understanding symptom contribution to sex inequality in bladder and renal cancer stage at diagnosis
by: Yin Zhou, et al.
Published: (2024)

Cumulative incidence and risk factors for recurrence of upper tract urothelial carcinoma in patients undergoing radical cystectomy
by: Ryo Yamashita, et al.
Published: (2024)

Waiting time in diagnosis and extirpative surgery and association with survival and stage progression in upper tract urothelial carcinomas
by: Fredrik Liedberg, et al.
Published: (2025)

Staging CT chest for cT1a renal masses: Does it change management?
by: Sanjana Ilangovan, et al.
Published: (2025)

Comparison of staging MRI to re‐resection for localised bladder cancer: Narrative review
by: Hugo Klempfner, et al.
Published: (2024)

Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
by: Arjun Pon Avudaiappan, et al.
Published: (2024)

Sequencing the Barcelona‐MRI predictive model and Proclarix for improving the uncertain PI‐RADS 3
by: Juan Morote, et al.
Published: (2024)

MRI performance to identify clinically significant prostate cancer following focal cryo‐ablation
by: Herbert Lepor, et al.
Published: (2025)

Muscle matters: Skeletal muscle index and body mass index impact on complications and survival in renal cancer
by: Alexander Hintze Hillers, et al.
Published: (2024)

The potential role of precision medicine to alleviate racial disparities in prostate, bladder and renal urological cancer care
by: Kunal K. Sindhu, et al.
Published: (2024)

Multivariable model integrating PHI and mpMRI for detecting csPCa in biopsy‐naïve men
by: Mario Dominguez Esteban, et al.
Published: (2025)

Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
by: Esther H. J. Hamoen, et al.
Published: (2025)

Impact of Mayo Adhesive Probability score and BMI on renal functional decline after robotic assisted partial nephrectomy
by: Cesare Saitta, et al.
Published: (2024)